Borut Štabuc

4.1k total citations
79 papers, 2.0k citations indexed

About

Borut Štabuc is a scholar working on Surgery, Immunology and Oncology. According to data from OpenAlex, Borut Štabuc has authored 79 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 22 papers in Immunology and 18 papers in Oncology. Recurrent topics in Borut Štabuc's work include Inflammatory Bowel Disease (14 papers), Gastric Cancer Management and Outcomes (9 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Borut Štabuc is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Gastric Cancer Management and Outcomes (9 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Borut Štabuc collaborates with scholars based in Slovenia, Belgium and United States. Borut Štabuc's co-authors include Maja Čemažar, Damijan Miklavčič, Z Rudolf, Gregor Serša, Janko Kos, Ana Schweiger, Ivan Vrhovec, Rado Janša, Nina Cimerman and David Drobne and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Borut Štabuc

74 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Borut Štabuc Slovenia 22 817 519 493 384 318 79 2.0k
Arun S. Singh United States 29 745 0.9× 523 1.0× 186 0.4× 485 1.3× 815 2.6× 113 2.4k
Raffaéle Palaia Italy 28 396 0.5× 432 0.8× 116 0.2× 385 1.0× 694 2.2× 87 2.3k
Katarína Kološtová Czechia 24 140 0.2× 187 0.4× 147 0.3× 399 1.0× 719 2.3× 76 1.5k
Huan Shi China 21 93 0.1× 244 0.5× 268 0.5× 555 1.4× 462 1.5× 55 1.5k
Vladimír Bobek Czechia 23 160 0.2× 214 0.4× 123 0.2× 371 1.0× 814 2.6× 68 1.5k
T G Pretlow United States 23 148 0.2× 283 0.5× 241 0.5× 1.1k 2.9× 615 1.9× 56 2.7k
Kiyoshi Yoshimura Japan 29 135 0.2× 120 0.2× 1.2k 2.5× 700 1.8× 1.2k 3.8× 87 2.4k
Gabriela B. Ferreira Belgium 15 66 0.1× 304 0.6× 993 2.0× 447 1.2× 348 1.1× 22 2.1k
Eduardo Castañón Spain 18 96 0.1× 311 0.6× 951 1.9× 583 1.5× 1.4k 4.3× 52 2.3k

Countries citing papers authored by Borut Štabuc

Since Specialization
Citations

This map shows the geographic impact of Borut Štabuc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Borut Štabuc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Borut Štabuc more than expected).

Fields of papers citing papers by Borut Štabuc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Borut Štabuc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Borut Štabuc. The network helps show where Borut Štabuc may publish in the future.

Co-authorship network of co-authors of Borut Štabuc

This figure shows the co-authorship network connecting the top 25 collaborators of Borut Štabuc. A scholar is included among the top collaborators of Borut Štabuc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Borut Štabuc. Borut Štabuc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Štabuc, Borut, et al.. (2025). Free and Bioavailable Vitamin D Are Correlated with Disease Severity in Acute Pancreatitis: A Single-Center, Prospective Study. International Journal of Molecular Sciences. 26(12). 5695–5695.
2.
3.
4.
Štabuc, Borut, et al.. (2021). TIPS vs . endoscopic treatment for prevention of recurrent variceal bleeding: a long-term follow-up of 126 patients. Radiology and Oncology. 55(2). 164–171. 8 indexed citations
5.
Hanžel, Jurij, Gregor Novak, Borut Štabuc, et al.. (2021). Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model. Pharmaceutics. 13(10). 1587–1587. 17 indexed citations
6.
Hanžel, Jurij, et al.. (2020). Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world study. Radiology and Oncology. 54(2). 233–236. 3 indexed citations
7.
Hanžel, Jurij, Gregor Novak, Borut Štabuc, et al.. (2020). Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission. Clinical Gastroenterology and Hepatology. 19(1). 111–118.e10. 32 indexed citations
8.
Drobne, David, et al.. (2019). Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 49(7). 880–889. 28 indexed citations
9.
Berzigotti, Annalisa, et al.. (2019). Muscle psoas indices measured by ultrasound in cirrhosis — Preliminary evaluation of sarcopenia assessment and prediction of liver decompensation and mortality. Digestive and Liver Disease. 51(11). 1502–1507. 33 indexed citations
10.
Hanžel, Jurij, Ivan Ferkolj, Borut Štabuc, et al.. (2019). Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease. United European Gastroenterology Journal. 7(6). 741–749. 21 indexed citations
11.
Novak, Gregor, Toer Stevens, Peter Bossuyt, et al.. (2019). Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease. Alimentary Pharmacology & Therapeutics. 49(11). 1401–1409. 17 indexed citations
12.
Drobne, David, Lojze Šmid, Ivan Ferkolj, et al.. (2018). Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease. Radiology and Oncology. 52(4). 443–452. 7 indexed citations
13.
Štubljar, David, Samo Jeverica, Tomislav Jukić, et al.. (2014). The influence of cytokine gene polymorphisms on the risk of developing gastric cancer in patients with Helicobacter pylori infection. Radiology and Oncology. 49(3). 256–264. 14 indexed citations
14.
Šereg‐Bahar, Maja, et al.. (2014). Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux – a prospective comparative study. Clinical Otolaryngology. 40(3). 234–239. 84 indexed citations
15.
Tepeš, Bojan & Borut Štabuc. (2011). Slovenian society for gastroenterology and hepatology guidelines on the management of Helicobacter pylori infection. SHILAP Revista de lepidopterología. 6 indexed citations
16.
Tepeš, Bojan, et al.. (2010). Slovenian colorectal cancer screenig programme SVIT–results of pilot phase. SHILAP Revista de lepidopterología. 3 indexed citations
17.
Štabuc, Borut, et al.. (2003). The urokinase plasminogen activator and its inhibitors PAI-1 and PAI-2 in primary cutaneous melanoma. Radiology and Oncology. 37(1). 1 indexed citations
18.
Bartenjev, Igor, et al.. (2000). Cathepsin D expression in early cutaneous malignant melanoma. International Journal of Dermatology. 39(8). 599–602. 19 indexed citations
19.
Mir, LM, Gregor Serša, Justin Teissié, et al.. (1998). Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. British Journal of Cancer. 77(12). 2336–2342. 356 indexed citations
20.
Serša, Gregor, et al.. (1998). Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. European Journal of Cancer. 34(8). 1213–1218. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arun S. Singh Breakdown of academic impact, for papers by Raffaéle Palaia Breakdown of academic impact, for papers by Katarína Kološtová Breakdown of academic impact, for papers by Huan Shi Breakdown of academic impact, for papers by Vladimír Bobek Breakdown of academic impact, for papers by T G Pretlow Breakdown of academic impact, for papers by Kiyoshi Yoshimura Breakdown of academic impact, for papers by Gabriela B. Ferreira Breakdown of academic impact, for papers by Eduardo Castañón
Rankless by CCL
2026